Solve MECFS Initiative

📢New Webinar!

In 2025, Simmaron Research was the second recipient of Solve’s ME/CFS Catalyst Award in support of its study, “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection-Associated Chronic Conditions.” The study hypothesizes that mTOR inhibition through rapamycin may address observed findings of autophagy impairment and symptoms in a subset of patients with ME/CFS and other infection-associated chronic conditions and illnesses (IACCIs).

The study advances an already FDA-approved drug for reducing key symptoms of ME/CFS and Long Covid, repurposing rapamycin to reduce fatigue, orthostatic intolerance, post-exertional malaise, and sleep issues for a subset of people with ME/CFS.

In this webinar hosted by Solve M.E. President Emily Taylor, panelists Courtney Miller (Board President at Simmaron), Dr. C. Gunnar Gottschalk (Chief Executive Officer at Simmaron), and Dr. Avik Roy (Chief Scientific Officer at Simmaron) will discuss the latest learnings from the study, and their plan to conduct an NIH exploratory treatment trial based on the data.

Register today for this free webinar with the Simmaron Research team at the link below.

When: Tues. July 14, @ 3:00 pm PT / 6:00 pm ET.

https://ow.ly/bG2H50Zg3Ct

Solve M.E. VP of Scientific Programs Dr. Jessica Maya and Advocacy Director Monique Wike are in San Diego this week for the 2026 BIO International Convention.

The theme this year is “Driven by Purpose,” with a focus on solving the impossible, pushing boundaries, and delivering better outcomes for patients, public health, and the world.

If you see them there, say hello!

Researchers at the University of Illinois Chicago are conducting a research study to better understand the effects of COVID-19 on exercise capacity, fatigue, physical activity, sleep, health markers in blood, and vascular health.

You may be eligible to participate if you are 18-45 years of age, have had COVID-19, and reside in or near the Chicagoland area. Contact [email protected] or (312) 996-9594 for more information!